Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nike Inc (NKE) vs Tilray Brands Inc (TLRY) Price & Performance

Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Nike Inc vs Tilray Brands Inc — how do they compare? Nike Inc trades at $37.14 (market cap $56.52B), while Tilray Brands Inc trades at $4.21 (market cap $591.60M). The key difference: Nike Inc is far larger — about 95.5× Tilray Brands Inc's market cap, and Nike Inc pays a 4.3% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

NKETLRY
Market Cap
$56.52B$591.60M
Volume
8,887,180
Sector
Consumer CyclicalHealth
52-Week High
$74.57$21.00
52-Week Low
$37.35$3.88
Enterprise Value
$58.53B$758.73M
Dividend Yield
4.3%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nike Inc

Nike (NKE) trades at $37.35, down 2.73% amid bearish technical signals and recent earnings volatility. The stock shows strong profitability metrics with 42.91% gross margins and 22.14% ROE, but faces revenue pressure with FY2025 sales declining to $46.31B. Analyst consensus remains positive with a $49.81 price target, though technical indicators signal caution with 17 sell signals versus 3 buy signals.

Nike's investment case balances strong brand equity and recent earnings beats against China market challenges and inventory pressures. The stock offers 33% upside to consensus targets but requires successful execution of the 'Win Now' turnaround strategy to overcome near-term headwinds in key markets.

Tilray Brands Inc

TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.

TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nike Inc

NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.

Read more on NKE

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY